Iberogast

Iberogast, the active ingredient in Iberogast, is a herbal medicine presented as an unspecified strength/liquid oral solution for oral use. It is used to relieve functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort in adults.

GNH USA supplies Iberogast as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Iberogast is indicated for disorders of the upper gastrointestinal tract that affect motility and sensation. - Functional dyspepsia: helps reduce post‑prandial fullness, early satiety and epigastric pain. - Irritable bowel syndrome: may alleviate abdominal discomfort and irregular bowel habits. - Gastrointestinal discomfort: provides symptomatic relief of bloating, nausea and mild cramping.

Iberogast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild abdominal discomfort: transient stomach upset. - Diarrhoea: loose stools that resolve with continued use. - Nausea: occasional feeling of queasiness. - Flatulence: increased intestinal gas. - Headache: mild, self‑limiting.

Serious or Rare Side Effects: - Allergic reaction: rash, itching or swelling. - Hepatic dysfunction: abnormal liver enzymes (very rare). - Severe hypersensitivity: anaphylaxis requiring immediate medical attention.

Before using Iberogast, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Liver disease: use with caution in patients with known hepatic impairment. - Concomitant herbal products: avoid simultaneous use of other potent herbal preparations. - Children: not recommended for use in children without medical advice. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Iberogast may interact with certain medicines; monitor accordingly.

Major Interactions (Avoid): - Cytochrome P450 substrates: potential alteration of metabolism for drugs heavily reliant on CYP enzymes. - Anticoagulants: possible increase in bleeding risk.

Moderate Interactions (Monitor Closely): - Antispasmodics: additive effects on gut motility. - Proton pump inhibitors: may affect absorption of some herbal constituents. - Other herbal remedies: risk of overlapping pharmacodynamic actions.